Sleep Apnea Reduced in People Who Took Weight-Loss Drug, Eli Lilly Reports

Health
By Gina Kolata from NYT Health https://ift.tt/i5dw7Bl
via IFTTT Sleep, Obesity, Clinical Trials, Drugs (Pharmaceuticals), Weight The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.

Comments

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women